Trials / Completed
CompletedNCT03848013
Treatment of Melasma Using Q-switched Nd: YAG Laser and Fractional CO2 Laser Separately and in Combination
Reatment of Melasma Using Q-switched Nd: YAG Laser and Fractional CO2 Laser Separately and in Combination
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Kasr El Aini Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
* All participants will be divided into 2 groups : Group A \& Group B. * Group A will be subjected to 3 consecutive sessions of Q-switched 1,064 nm Nd: YAG laser to one side of the face \& fractional co2 laser to the other side of the face with one month interval between sessions. * Group B will be subjected also to 3 consecutive sessions of Q-switched 1,064 nm Nd: YAG laser to one side of the face \& an additional fractional co2 laser to the other side of the face using the above mentioned parameters with one month interval between sessions. * Response to treatment will be assessed using the Melanin Index (MI) score, Melasma Area and Severity Index (MASI) score, spectrophotometer ( Derma catch, colorix, Neuchatel, Switzerland ) and a subjective self-assessment method.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Q switched Nd YAG laser | Laser device emitting Q switched Nd YAG aiming for skin toning |
| DEVICE | Fractional CO2 laser | Laser device emitting fractionated ablative laser aiming for skin resurfacing |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2019-04-01
- Completion
- 2019-06-01
- First posted
- 2019-02-20
- Last updated
- 2020-01-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03848013. Inclusion in this directory is not an endorsement.